undamentalytics Newsletter

Jones Steven C: insider trades

Officer, Director at Neogenomics Inc. No open-market purchases and 21 sales not made under a pre-set plan, reported from October 1, 2012 to December 14, 2020.

What happened after Jones Steven C’s sales?

After their sales, the shares moved +26.4% against the index over 12 months on average (a negative figure means selling was the right call); 17% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Jones Steven C: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 18 +6.7% +3.3% 33% 5 0.81 0.46 No reliable evidence
Sales, 12 months after the report 18 +26.4% +36.1% 17% 5 0.86 0.44 No reliable evidence
Sales, 12 months after the trade 18 +26.4% +32.4% 22% 5 0.86 0.44 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Neogenomics Inc NEO Executive Vice President021October 1, 2012December 14, 2020

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
December 14, 2020December 10, 2020 NEO Sale $3,560,750 −12.1%−67.3%−66.0%
December 7, 2020December 3, 2020 NEO Sale $6,311,310 −7.3%−58.7%−61.8%
September 30, 2020September 28, 2020 NEO Sale $10,282,430 +34.7%+1.0%−3.7%
September 10, 2020September 8, 2020 NEO Sale $4,434,437 +31.8%+10.2%+4.5%
March 4, 2020March 2, 2020 NEO Sale $8,554,252 −13.5%+12.3%+47.6%
November 22, 2019November 20, 2019 NEO Sale $3,680,598 +11.7%+57.4%+57.6%
September 10, 2019September 6, 2019 NEO Sale $68,114 +14.1%+50.3%+27.8%
August 30, 2019August 28, 2019 NEO Sale $1,019,216 −1.3%+37.3%+31.5%
August 27, 2019August 23, 2019 NEO Sale $4,518,661 −2.6%+31.5%+33.3%
February 28, 2019February 26, 2019 NEO Sale $5,668,743 +13.8%+40.3%+45.5%
November 14, 2018November 12, 2018 NEO Sale $2,351,235 +12.7%+34.9%+25.4%
August 1, 2018July 30, 2018 NEO Sale $2,849,411 +34.8%+65.3%+68.4%
June 26, 2018June 22, 2018 NEO Sale $1,259,220 +1.2%+49.7%+52.8%
June 19, 2018June 15, 2018 NEO Sale $2,135,216 +2.9%+64.8%+74.5%
June 5, 2018June 1, 2018 NEO Sale $2,794,060 +6.0%+83.7%+75.1%
May 31, 2018May 29, 2018 NEO Sale $1,979,736 +3.7%+75.1%+77.2%
May 3, 2016May 2, 2016 NEO Sale $1,459,286 +0.2%−21.9%−24.5%
November 27, 2015November 25, 2015 NEO Sale $3,117,100 −9.9%+9.3%+9.5%
May 1, 2013April 29, 2013 NEO Sale $371,153 not yetnot yetnot yet
December 20, 2012December 18, 2012 NEO Sale $1,763,957 not yetnot yetnot yet
October 1, 2012September 26, 2012 NEO Sale $184,048 not yetnot yetnot yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Jones Steven C traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.